Fordyce Marshall's Form 4 filing
Vera Therapeutics, Inc. (VERA) · filed Sep 13, 2024
- Accession no.
- 0001415889-24-023372
- Filed
- Sep 13, 2024
- Trade date
- Sep 11, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $586.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fordyce MarshallCIK 0001859453 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2024 | Class A Common Stock | MOption exerciseAcquired | +9,274 | $2.90 | +$26,894.6 | 317,246 | Direct | |
| Sep 11, 2024 | Class A Common Stock | SSaleDisposed | −9,274 | $37.31 | −$346,012.94 | 307,972 | Direct | |
| Sep 11, 2024 | Class A Common Stock | MOption exerciseAcquired | +6,351 | $2.90 | +$18,417.9 | 314,323 | Direct | |
| Sep 11, 2024 | Class A Common Stock | SSaleDisposed | −6,351 | $37.78 | −$239,940.78 | 307,972 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2024 | Class A Common Stock | MOption exerciseDisposed | −15,625 | $0.00 | $0 | 827,337 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.